Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Granada – page 4

395 clinical trials in Granada, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Granada at a glance
395
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

395 trials in Granada

Open in trial search

Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic vein tissue segment, decellularised, with a functional valve perfused with autologous peripheral blood
  • Sponsor:VeriGraft AB

A study of acalabrutinib and venetoclax for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have relapsed after initial treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:AstraZeneca AB

A study comparing BGB-11417 and zanubrutinib with venetoclax and acalabrutinib for patients with previously untreated chronic lymphocytic leukemia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BeOne Medicines I GmbH

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid

A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sigvotatug vedotin
  • Sponsor:Pfizer Inc.

Hidradenitis

Recruiting

A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Almirall S.A.

Study of Grass Pollen Extract and Olive Pollen Extract for Patients with Hay Fever and Asthma caused by Grass and Olive Pollen Allergies

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.

A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Pfizer Inc.

Breast cancer

Recruiting

Study of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:F. Hoffmann-La Roche AG

Breast cancer+4

Recruiting

Study of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Elacestrant
  • Sponsor:WSG Women's Cancer Study Group GmbH

Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Granada

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on multiple cancer types including colorectal cancer, breast cancer, and glioblastoma. Studies are evaluating novel treatment approaches and combination therapies.

  • Metastatic colorectal cancer treatment optimization
  • Triple-negative breast cancer therapies
  • Prostate cancer diagnostics and treatment

Advanced imaging techniques and targeted therapies are being investigated to improve patient outcomes.

02 Respiratory Medicine

Research targeting respiratory conditions with a focus on chronic obstructive pulmonary disease. Studies are examining new therapeutic approaches for moderate to severe cases.

  • COPD exacerbation management
  • Novel therapeutic antibodies
  • Bronchial disease treatments

Emphasis on reducing disease progression and improving quality of life for patients.

03 Dermatology Studies

Clinical investigations in various skin conditions including plaque psoriasis and atopic dermatitis. Research focuses on innovative biological treatments.

  • Moderate to severe psoriasis therapies
  • Hidradenitis suppurativa treatments
  • Novel dermatological interventions

Trials aim to develop more effective treatments for chronic skin conditions.

04 Neurological Research

Studies investigating treatments for Alzheimer's disease in specific populations, particularly focusing on prevention and management of associated conditions.

  • Alzheimer's disease in Down syndrome
  • Seizure prevention strategies
  • Neurological disorder management

Research aims to improve quality of life for patients with complex neurological conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.